More than 40,000 previously unknown gut microbes in African populations could completely change how medicines work for millions of people, according to scientists.
Savara’s rare lung disease treatment passes Phase 3
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS